Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Bioinformatics Analysis of Gene Expression Profiles for Diagnosing Sepsis and Risk Prediction in Patients with Sepsis

ABSTRACT: Bioinformatics Analysis of Gene Expression Profiles for Diagnosing Sepsis and Risk Prediction in Patients with Sepsis

PROVIDER: PRJNA973696 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR24633016.fastq.gz	Fastqsanger.gz
	SRR24633017.fastq.gz	Fastqsanger.gz
	SRR24633018.fastq.gz	Fastqsanger.gz
	SRR24633019.fastq.gz	Fastqsanger.gz
	SRR24633020.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 28

Similar Datasets

Bioinformatics Analysis of Gene Expression Profiles for Diagnosing Sepsis and Risk Prediction in Patients with Sepsis

Project description:This study aimed to compare gene expression profiles between patients with sepsis and healthy volunteers, to determine the accuracy of these profiles in diagnosing sepsis, and to predict sepsis outcomes by combining bioinformatics data with molecular experiments and clinical information.

2023-05-19 | GSE232753 | GEO

Circulating microRNA expression patterns and target prediction in sepsis development

Project description:To screen the circulating miRNAs which can be used to evaluate the diagnosis and prognosis of sepsis by gene microarray,and to predict its target gene and mechanism by bioinformatics analysis in sepsis. To screen the circulating miRNAs which can be used to evaluate the diagnosis and prognosis of sepsis by gene microarray,and to predict its target gene and mechanism by bioinformatics analysis in sepsis.

2020-07-19 | GSE101639 | GEO

Serum miRNA-based risk prediction for stroke

Project description:Serum miRNA-based risk prediction for stroke

| PRJNA480974 | ENA

Leukocytes from patients with sepsis

Project description:To examine whether gene-expression profiling of circulating leukocytes is different between patients with sepsis as compared to controls. The signature genes identified will then be used to develop a prediction model to assist the diagnosis of sepsis. Keywords: Prediction study

2007-07-01 | GSE5772 | GEO

Risk assessment with gene expression markers in sepsis development

Project description:Risk assessment with gene expression markers in sepsis development

| PRJNA860175 | ENA

Risk assessment with gene expression markers in sepsis development

Project description:Risk assessment with gene expression markers in sepsis development

| PRJNA860181 | ENA

Expression data for tumor and normal tissue samples from deceased sepsis and non-sepsis colorectal cancer patients

Project description:The mortality risk from cancer-associated sepsis is differentially affected by individual cancer sites and host responses to sepsis are heterogenous. Native Hawaiians have a 2-fold higher mortality risk from cancer-associated sepsis than Whites and also higher mortality risk from colorectal cancer (CRC). We investigated this disparity by examining ethnic variation in the transcriptome of patients with CRC-associated sepsis and its relation to survival and genetic diversity. We conducted transcriptomic profiling of CRC tumors and adjacent non-tumor tissue obtained from adult patients of Native Hawaiian and Japanese ethnicity who died from cancer-associated sepsis. We examined differential gene expression in relation to patient survival and sepsis disease etiology.

2022-09-01 | GSE198103 | GEO

Transcriptional instability in sepsis

Project description:The temporal evolution of sepsis was monitored by transcriptional profiling of five critically ill children with meningococcal sepsis and sepsis-induced multiple organ failure. Blood was sampled at 6 time points during the first 48 hours of their admission to pediatric intensive care, where the children received standard clinical treatment including organ support and antimicrobial therapy. Striking transcript instability was observed over the 48 hours, with increasing numbers of regulated genes over time. Most notably, proposed biomarkers for sepsis risk stratification also showed expression instability, with varied expression levels over 48 hours. This study demonstrates the extent of the complexity of temporal changes in gene expression that occur during the evolution of sepsis-induced multiple organ failure. Importantly, stratification tools that propose expression of biomarkers must take into account the temporal changes, over the use of single snapshots that may be less informative.

2013-04-03 | E-MEXP-3850 | biostudies-arrayexpress

Gene-expression profiling of peripheral blood mononuclear cells in sepsis

Project description:To identify signature genes that help distinguish (1) sepsis from non-infectious causes of systemic inflammatory response syndrome, (2) between Gram-positive and Gram-negative sepsis. Keywords: Class prediction study

2009-04-01 | GSE9960 | GEO

Risk prediction models for dementia constructed by supervised principal component analysis using miRNA expression data

Project description:Alzheimer’s disease (AD) is the most common subtype of dementia, followed by Vascular Dementia (VaD), and Dementia with Lewy Bodies (DLB). Recently, microRNAs (miRNAs) have received a lot of attention as the novel biomarkers for dementia. Here, using serum miRNA expression of 1,601 Japanese individuals, we investigated potential miRNA bio- markers and constructed risk prediction models, based on a supervised principal component analysis (PCA) logistic regression method, according to the subtype of dementia. The final risk prediction model achieved a high accuracy of 0.873 on a validation cohort in AD, when using 78 miRNAs: Accuracy = 0.836 with 86 miRNAs in VaD; Accuracy = 0.825 with 110 miRNAs in DLB. To our knowledge, this is the first report applying miRNA-based risk pre- diction models to a dementia prospective cohort. Our study demonstrates our models to be effective in prospective disease risk prediction; and with further improvement may contribute to practical clinical use in dementia.

2019-02-26 | GSE120584 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data